Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?

PURPOSE: We aimed to compare the overall (OS) and disease-free survival (DFS) of patients undergoing orthotopic liver transplant (OLT) for hepatocellular carcinoma who did and did not have neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE). METHODS: This is a retros...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diagn Interv Radiol
Prif Awduron: Dorcaratto, Dimitri, Udupa, Venkatesha, Hogan, Niamh M., Brophy, David P., McCann, Jeffrey W., Maguire, Donal, Geoghegan, Justin, Cantwell, Colin P., Hoti, Emir
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Turkish Society of Radiology 2017
Pynciau:
Interventional Radiology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669544/
https://ncbi.nlm.nih.gov/pubmed/29063856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/dir.2017.17106
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg